Immunostimulatory monoclonal antibodies for cancer therapy
Ignacio Melero(University of Oxford), Lieping Chen(Yale Cancer Center)
Cited by 628
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5k
Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
|Journal of Clinical Investigation|2015|1.4k
Cytokines in clinical cancer immunotherapy
|British Journal of Cancer|2018|1.2k
Programmed death ligand-1 expression in non-small cell lung cancer
|Laboratory Investigation|2013|753